Specify a stock or a cryptocurrency in the search bar to get a summary
Tonghua Dongbao Pharmaceutical Co Ltd
600867Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. The company operates through Pharmaceutical Industry; Building Materials Industry; and Real Estate Industry segments. It offers human insulin raw materials and injection, insulin glargine raw materials and injection, insulin aspart API and injection, Zhennaoning capsules, and diabetes-related medical devices. Further, it provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient management system. It offers building materials.Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China. Address: Dongbao New Village, Tonghua, China, 134123
Analytics
WallStreet Target Price
92.71 CNYP/E ratio
48.7778Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 600867
Dividend Analytics 600867
Dividend growth over 5 years
25 %Continuous growth
–Payout Ratio 5 years average
48 %Dividend History 600867
Stock Valuation 600867
Financials 600867
Results | 2019 | Dynamics |